Market Place
Sourcing Support
Stryker Completes Inari Buy, Enters Peripheral Vascular Market
19 Feb 2025 //
GLOBENEWSWIRE
Stryker Launches Tender Offer For Inari Medical`s Outstanding Share
17 Jan 2025 //
GLOBENEWSWIRE
Device maker Stryker strikes $4.9 billion deal for Inari Medical
07 Jan 2025 //
REUTERS
Stryker To Acquire Inari, Entering Peripheral Vascular Market
06 Jan 2025 //
GLOBENEWSWIRE
Inari Medical to Present at the J.P. Morgan Healthcare Conference
03 Jan 2025 //
GLOBENEWSWIRE
Inari Medical Announces Joint Venture in Greater China
02 Dec 2024 //
GLOBENEWSWIRE
Inari Medical`s ClotTriever® Approved For Reimbursement In Japan
02 Dec 2024 //
GLOBENEWSWIRE
Inari Medical to Attend Jefferies London Healthcare Conference
06 Nov 2024 //
GLOBENEWSWIRE
Peerless Results Show FlowTriever® Superior to Thrombolytics
29 Oct 2024 //
GLOBENEWSWIRE
Inari Medical Reports Third Quarter 2024 Financial Results
28 Oct 2024 //
#N/A
Inari Medical Announces Partnership withNBCA on DEFIANCE Trial
15 Oct 2024 //
GLOBENEWSWIRE
Inari Medical to Announce Third Quarter 2024 Financial Results
07 Oct 2024 //
GLOBENEWSWIRE
Inari Medical To Host Meeting After PEERLESS RCT Presentation
07 Oct 2024 //
GLOBENEWSWIRE
Inari Medical to Present PEERLESS Data at TCT 2024 Clinical Trial Sessions
29 Aug 2024 //
GLOBENEWSWIRE
US FDA classifies recall of Inari`s catheter devices as `most serious`
24 Aug 2024 //
REUTERS
Inari Medical to Present at Upcoming Investor Conferences
21 Aug 2024 //
GLOBENEWSWIRE
Inari Medical Reports Second Quarter 2024 Financial Results
30 Jul 2024 //
GLOBENEWSWIRE
Inari Medical Announces Chief Financial Officer Retirement and Succession Plan
30 Jul 2024 //
GLOBENEWSWIRE
Inari Medical to Announce Second Quarter 2024 Financial Results
16 Jul 2024 //
GLOBENEWSWIRE
Inari Medical Lawsuit Filed: Patent Infringement Against Competitors
23 May 2024 //
GLOBENEWSWIRE
Inari To Participate In BofA Healthcare Conference 2024
06 May 2024 //
GLOBENEWSWIRE
Inari Medical Reports First Quarter 2024 Financial Results
30 Apr 2024 //
GLOBENEWSWIRE
Inari Medical to Announce First Quarter 2024 Financial Results
17 Apr 2024 //
GLOBENEWSWIRE
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
11 Apr 2024 //
GLOBENEWSWIRE
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
02 Apr 2024 //
GLOBENEWSWIRE
Inari Announces Interim Two-Year Results from the ClotTriever CLOUT Registry
12 Mar 2024 //
GLOBENEWSWIRE
Inari Medical Reports Fourth Quarter 2023 Financial Results
28 Feb 2024 //
GLOBENEWSWIRE
Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
14 Feb 2024 //
GLOBENEWSWIRE
Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance
09 Jan 2024 //
GLOBENEWSWIRE
Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
20 Dec 2023 //
GLOBENEWSWIRE
Inari Medical Announces First Patient Enrollment in PEERLESS II RCT
27 Nov 2023 //
GLOBENEWSWIRE
Inari Medical Closes Acquisition of LimFlow
15 Nov 2023 //
GLOBENEWSWIRE
Inari Medical to Present at Upcoming Investor Conferences
02 Nov 2023 //
GLOBENEWSWIRE
Inari Medical Expands Patient-Focused Mission with Agreement to Acquire LimFlow
01 Nov 2023 //
GLOBENEWSWIRE
Inari Medical Reports Third Quarter 2023 Financial Results
01 Nov 2023 //
GLOBENEWSWIRE
Inari Medical to Announce Third Quarter 2023 Financial Results
11 Oct 2023 //
GLOBENEWSWIRE
Inari Medical to Present at Upcoming Investor Conferences
24 Aug 2023 //
GLOBENEWSWIRE
Inari Medical Reports Second Quarter 2023 Financial Results
02 Aug 2023 //
GLOBENEWSWIRE
Inari Medical to Present at the 43rd Annual Canaccord Growth Conference
26 Jul 2023 //
GLOBENEWSWIRE
Inari Medical to Announce Second Quarter 2023 Financial Results
13 Jul 2023 //
GLOBENEWSWIRE
Inari Medical Announces Commercial Launch of RevCore and Triever16 Curve
07 Jun 2023 //
GLOBENEWSWIRE
Inari Medical Announces PEERLESS II, a Randomized Controlled Trial
22 May 2023 //
GLOBENEWSWIRE
Inari Medical Reports 1Q 2023 Financial Results
03 May 2023 //
GLOBENEWSWIRE
Inari Medical to Present at the Bank of America 2023 Healthcare Conference
02 May 2023 //
GLOBENEWSWIRE
Inari Medical to Announce First Quarter 2023 Financial Results
13 Apr 2023 //
GLOBENEWSWIRE
FLAME Study Demonstrate 90% Survival Improvement in High-Risk Pulmonary Embolism
06 Mar 2023 //
GLOBENEWSWIRE
Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results
27 Feb 2023 //
GLOBENEWSWIRE
Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
07 Feb 2023 //
GLOBENEWSWIRE
Inari Medical to Participate Virtually at the BTIG Diagnostic Tools Conference
31 Jan 2023 //
GLOBENEWSWIRE
Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial
12 Jan 2023 //
GLOBENEWSWIRE
Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance
10 Jan 2023 //
GLOBENEWSWIRE
Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
21 Dec 2022 //
GLOBENEWSWIRE
Inari Medical Announces 30-day Outcomes from the Fully Enrolled CLOUT Registry
31 Oct 2022 //
GLOBENEWSWIRE
Inari Medical Announces Results from the Fully Enrolled 800-patient US Cohort
19 Sep 2022 //
GLOBENEWSWIRE
Inari Medical Announces Three New Data Sets to be Presented DuringLate-Breaking
01 Sep 2022 //
GLOBENEWSWIRE
Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes
30 Aug 2022 //
GLOBENEWSWIRE
Inari Medical to Present at Upcoming Investor Conferences
25 Aug 2022 //
GLOBENEWSWIRE
Inari Medical Reports Second Quarter 2022 Financial Results
03 Aug 2022 //
GLOBENEWSWIRE
Inari Medical to Announce Second Quarter 2022 Financial Results
18 Jul 2022 //
GLOBENEWSWIRE
Inari Medical Announces Launch of 2021 Ethos and Sustainability Report
13 May 2022 //
GLOBENEWSWIRE
